• Je něco špatně v tomto záznamu ?

Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology

M. Pohanka,

. 2012 ; 13 (2) : 2219-38.

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc13016176

Alpha7 nicotinic acetylcholine receptor (α7 nAChR) is an important part of the cholinergic nerve system in the brain. Moreover, it is associated with a cholinergic anti-inflammatory pathway in the termination of the parasympathetic nervous system. Antagonists of α7 nAChR are a wide group represented by conotoxin and bungarotoxin. Even Alzheimer's disease drug memantine acting as an antagonist in its side pathway belongs in this group. Agonists of α7 nAChR are suitable for treatment of multiple cognitive dysfunctions such as Alzheimer's disease or schizophrenia. Inflammation or even sepsis can be ameliorated by the agonistic acting compounds. Preparations RG3487, SEN34625/WYE-103914, SEN12333, ABT-107, Clozapine, GTS-21, CNI-1493, and AR-R17779 are representative examples of the novel compounds with affinity toward the α7 nAChR. Pharmacological, toxicological, and medicinal significance of α7 nAChR are discussed throughout this paper.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13016176
003      
CZ-PrNML
005      
20130424134815.0
007      
ta
008      
130424s2012 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms13022219 $2 doi
035    __
$a (PubMed)22408449
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pohanka, Miroslav $u Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 50001 Hradec Kralove, Czech Republic; E-Mail: miroslav.pohanka@gmail.com ; Tel.: +420-973253091;
245    10
$a Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology / $c M. Pohanka,
520    9_
$a Alpha7 nicotinic acetylcholine receptor (α7 nAChR) is an important part of the cholinergic nerve system in the brain. Moreover, it is associated with a cholinergic anti-inflammatory pathway in the termination of the parasympathetic nervous system. Antagonists of α7 nAChR are a wide group represented by conotoxin and bungarotoxin. Even Alzheimer's disease drug memantine acting as an antagonist in its side pathway belongs in this group. Agonists of α7 nAChR are suitable for treatment of multiple cognitive dysfunctions such as Alzheimer's disease or schizophrenia. Inflammation or even sepsis can be ameliorated by the agonistic acting compounds. Preparations RG3487, SEN34625/WYE-103914, SEN12333, ABT-107, Clozapine, GTS-21, CNI-1493, and AR-R17779 are representative examples of the novel compounds with affinity toward the α7 nAChR. Pharmacological, toxicological, and medicinal significance of α7 nAChR are discussed throughout this paper.
655    _2
$a časopisecké články $7 D016428
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 13, č. 2 (2012), s. 2219-38
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22408449 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20130424 $b ABA008
991    __
$a 20130424135103 $b ABA008
999    __
$a ind $b bmc $g 979377 $s 814497
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 13 $c 2 $d 2219-38 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20130424

Najít záznam

Citační ukazatele

Možnosti archivace